Dec 31, 2020

Hannon Armstrong Q4 2020 Earnings Report

Reported results for the fourth quarter and full year of 2020.

Key Takeaways

Hannon Armstrong delivered strong results for Q4 2020, with distributable earnings per share above guidance and significant growth in the investment pipeline and portfolio. The company issued new three-year guidance of 7% to 10% compound annual growth in distributable earnings per share.

Delivered $1.10 GAAP EPS on a fully diluted basis in 2020.

Delivered $1.55 Distributable (Core Pre-CECL) EPS on a fully diluted basis in 2020, representing 11% year-on-year growth.

Grew balance sheet portfolio 38% year-on-year to $2900000000 and managed assets 16% to $7200000000 as of the end of 2020.

Increased dividend to $0.35 per share for the first quarter of 2021

Total Revenue
$24.5M
Previous year: $21.9M
+11.8%
EPS
$0.37
Previous year: $0.4
-7.5%
Dividend per share
$0.35
Previous year: $0.34
+2.9%
Gross Profit
$48.9M
Previous year: $38.3M
+27.6%
Cash and Equivalents
$286M
Previous year: $6.21M
+4511.0%
Total Assets
$3.46B
Previous year: $2.39B
+44.9%

Hannon Armstrong

Hannon Armstrong

Forward Guidance

The Company expects that annual distributable earnings per share will grow at a compounded annual rate of 7% to 10% from 2021 to 2023, relative to the 2020 baseline of $1.55 per share, which is equivalent to a 2023 midpoint of $1.98 per share. The Company also expects that annual dividends per share will grow at a compound annual rate of 3% to 5% from 2021 to 2023, relative to the 2020 baseline of $1.36 per share, which is equivalent to a 2023 midpoint of $1.53 per share.

Positive Outlook

  • Yield on its existing Portfolio
  • Yield on incremental Portfolio investments, inclusive of the Company’s existing pipeline
  • The volume and profitability of securitization transactions
  • Amount, timing, and costs of debt and equity capital to fund new investments
  • Changes in costs and expenses reflective of the Company’s forecasted operations

Challenges Ahead

  • The ongoing impact of COVID-19 and the speed and efficacy of vaccine distribution on economic conditions
  • The general interest rate and market environment
  • The regulatory environment
  • The dynamics of the markets in which we operate
  • The judgment of the Company’s management team